Women were less than half of the people tested for almost all of these common medicines.

NCT01154036

MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

See it on ClinicalTrials.gov β†—

1,547 people

813 womenmiddle line = equal numbers734 men
Phase
PHASE3
Paid for by
Organon and Co
Finished
2012-10
Health conditions
Hypercholesterolemia
Who could join
Anyone
Ages
18 Years – 79 Years
Average age
Not reported
Age 65+
32.8%
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Not reported

Women left out

  • No pregnant women

    Women who were pregnant could not join.

    β€œFemale patient is pregnant or breastfeeding”
  • No breastfeeding moms

    Women who were breastfeeding could not join.

    β€œFemale patient is pregnant or breastfeeding”
  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    β€œPatient has kidney disease”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    β€œPatient has congestive heart failure”
  • No diabetes

    Women with diabetes were turned away.

    β€œPatient has poorly controlled or newly diagnosed diabetes”
  • No cancer

    Women with current or past cancer were turned away.

    β€œPatient has a history of cancer in the last 5 years, except certain skin and cervical cancers”

Study titles and rules are shown in their original English.